World’s second largest brewer says use of drugs such as Wegovy can reduce desire to drink alcohol • Business live – latest updates Heineken has warned British bars and pubs that the boom in popularity of weight-loss drugs could lead to a fall in sales of beer and cider. The world’s second-largest brewer sent a presentation to British hospitality customers earlier this month that said the use of GLP-1 medication – such as Ozempic and Wegovy – could reduce the desire to drink alcohol . This in turn could result in “fullness and fewer serves” of pints in pubs and bars, it added. Continue reading...
Boom in weight-loss drugs could lead to fall in beer sales, Heineken warns UK pubs
Source: The Guardian
Original reporting
The Guardian: read the full reportFollow this story
Earlier reports and follow-ups on the same developing story.
Related stories
BBC Business2 outlets
What is PHP and why did it spark a global cyber-security scramble?
AI uncovered long-hidden programming flaws, triggering a rare global cyber-security response.
CNBC
Silicon Valley Democrats demand investigation into Starlink restrictions in Ukraine
A letter demanding an investigation indicates Democrats will make investigating Starlink's interruption a top priority if they win control of the U.S. House.
CNBC
Higher interest rates have made family offices pickier about investing in real estate
Higher interest rates have made family offices more selective about investing in real estate.
CNBC
10-year Treasury yield drops back to 5% this week as investors seek cover from AI worries
U.S. Treasury yields edged higher on Friday following a sharp reversal on Thursday.
CNBC
Fewer people are flying as airfare soars. Here's why airlines aren't worried
Airlines are reporting fewer people flew in the third quarter as airfare surged on fuel costs, but executives say travelers are mostly swallowing higher fares.
CNBC
On the ground at Nvidia's AI showpiece: Jensen-mania, robot ducks and neocloud distress
The word on the ground from Nvidia's GTC conference in Berlin.